trial
as of 2026-07-01A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia
NCTId NCT02880462
at a glance
Phase 2 · Completed
Enrollment 172 (actual)
Sponsored by Central South University
Primary completion 2019-05-20
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 2
Status
Completed
Enrollment
172 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2016-12-26
Primary completion
2019-05-20
Eligibility
ALL · 18 Years · 50 Years
Interventions & indications
Drugs
Indications
Sponsors
Central South UniversityLead Sponsor
Stanley Medical Research InstituteCollaborator
Investigators
4
Jianjun Ou, M.D Ph.DPrincipal Investigator
Renrong Wu, M.D., Ph.D.Principal Investigator
Jingping Zhao, M.D Ph.DStudy Chair
Hua Jin, M.D Ph.DPrincipal Investigator
Sites
0 total
Linked catalysts
1
Facts & assertions
4 sourced
Enrollment
172
Phase
PHASE2
Primary Completion Date
2019-05-20
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
company
collaborator
indication
indication
indication
investigator
person
person
person
person